(Q44866619)
Statements
1 reference
Doxercalciferol safely suppresses PTH levels in patients with secondary hyperparathyroidism associated with chronic kidney disease stages 3 and 4. (English)
1 reference
Jack W Coburn
1 reference
Hla M Maung
1 reference
Logan Elangovan
1 reference
Michael J Germain
1 reference
Jill S Lindberg
1 reference
Stuart M Sprague
1 reference
Mark E Williams
1 reference
Charles W Bishop
1 reference
1 May 2004
1 reference
1 reference
43
1 reference
5
1 reference
877-890
1 reference
Identifiers
1 reference
1 reference